Αποτελέσματα Αναζήτησης
An experimental drug from Eli Lilly helped patients with obesity lose an average of 24% of their body weight over 48 weeks on the highest dose in a mid-stage study, the most weight loss seen...
- GLP-1 pills are coming, and they could revolutionize weight-loss ... - CNN
At least a dozen experimental weight-loss drugs designed to...
- At least 25,000 people in the US are starting weight-loss drug ... - CNN
Drugmaker Novo Nordisk said it’s been increasing supply of...
- GLP-1 pills are coming, and they could revolutionize weight-loss ... - CNN
At least a dozen experimental weight-loss drugs designed to be taken as pills are working their way through clinical trials, with the most advanced now in the third and final stage of testing.
8 Νοε 2023 · An obesity drug called Zepbound won approval for use in adults from the Food and Drug Administration Wednesday, ushering in a new rival to Novo Nordisk's blockbuster Wegovy.
8 Νοε 2023 · The FDA has approved Zepbound, an injectable weight loss drug from Eli Lilly that helped people lose up to 52 lbs in 16 months during clinical trials.
26 Ιουν 2023 · New data from Eli Lilly show two of its anticipated weight-loss drugs— tirzepatide (Mounjaro) and orforglipron—were effective in recent studies.
29 Ιουν 2023 · There are three versions of pills being studied that may be as effective for weight loss as Ozempic, all with different ingredients — one by Novo Nordisk, one by Eli Lilly and one by Pfizer....
2 Μαΐ 2024 · Drugmaker Novo Nordisk said it’s been increasing supply of its sought-after weight-loss drug Wegovy, with at least 25,000 people now starting to take the medicine each week in the United States....
